Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ридженерон Фармасьютикалз, Инк.filedCriticalРидженерон Фармасьютикалз, Инк.
Priority claimed from PCT/US2019/031879external-prioritypatent/WO2019217927A1/en
Publication of EA202092700A1publicationCriticalpatent/EA202092700A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Данное изобретение относится к офтальмологическим составам, имеющим высокие концентрации слитого белка рецептора фактора роста сосудистого эндотелия (ФРЭС) и высокую стабильность при хранении. Также предложены способы лечения ангиогенных заболеваний глаз с применением высококонцентрированных составов.This invention relates to ophthalmic formulations having high concentrations of vascular endothelial growth factor receptor (VEGF) fusion protein and high storage stability. Also proposed are methods for the treatment of angiogenic eye diseases using highly concentrated formulations.
EA202092700A2019-03-052019-05-10
COMPOSITIONS CONTAINING VEGETABLE RECEPTOR PROTEIN IN HIGH CONCENTRATION
EA202092700A1
(en)
Pharmaceutical composition for preventing and treating eye diseases, containing, as active ingredient, fusion protein in which tissue-penetrating peptide and anti-vascular endothelial growth factor preparation are fused